Selected Publications (First/correspondent author)

Research articles

1. The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction. Signal Transduction and Targeted Therapy, 2021 Jul 12;6(1):266. 

2. A novel CAD risk gene JCAD/KIAA1462 promotes endothelial dysfunction and atherosclerosis. European Heart Journal, 2019, 40: 2398–2408 (Highlighted article accompanied by three commentaries).

3. SENCR Stabilizes Vascular Endothelial Cell Adherens Junction through Interaction with CKAP4. Proc Natl Acad Sci U S A, 2019 Jan 8;116(2):546-555.

4. Flow-dependent epigenetic regulation of IGFBP5 expression by H3K27me3 contributes to endothelial anti-inflammatory effects. Theranostics, 2018, 8(11):3007-3021.

​

Invited review articles

1. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies. Pharmacological Reviews. 2021 Jul;73(3):924-967.

2. Impact of sodium glucose cotransporter 2 (SGLT2) inhibitors on atherosclerosis: from pharmacology to pre-clinical and clinical therapeutics. Theranostics. 2021 Mar 4;11(9):4502-4515. 

3. GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential. Int J Biol Sci 2021; 17(8):2050-2068.

4. Targeting foam cell formation in atherosclerosis: therapeutic potential of natural products. Pharmacological Reviews,  2019 Oct;71(4):596-670

5. Hutchinson-Gilford Progeria Syndrome: Cardiovascular Pathologies and Potential Therapies. Trends in Biochemical Sciences. 2019 Jul;44(7):561-564.

6. Targeting Mechanosensitive Transcription Factors in Atherosclerosis. Trends in     

       Pharmacological Sciences. 2019 Apr;40(4):253-266.

​

ESI highly cited articles

1. Flavonoid biosynthetic pathways in plants: Versatile targets for metabolic engineering. Biotechnology advances. 2020;38:107316.

2. Curcumin, the golden spice in treating cardiovascular diseases. Biotechnology advances. 2020; 38, 107343.

3. Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics. Theranostics. 2019 Mar 16;9(7):1923-1951.

4. Targeting Mechanosensitive Transcription Factors in Atherosclerosis. Trends Pharmacol Sci. 2019 Apr;40(4):253-266. 

5. Salvia miltiorrhizaBurge (Danshen): A Golden Herbal Medicine in Cardiovascular Therapeutics. Acta Pharmacol Sin​. 2018 May;39(5):802-824

6. Atheroprotective Effects and Molecular Targets of Tanshinones Derived From Herbal Medicine Danshen. Med Res Rev. 2018 Jan;38(1):201-228. 

7. Cardiovascular Actions and Therapeutic Potential of Tanshinone IIA. Atherosclerosis. 2012 Jan;220(1):3-10.